000 | 01615 a2200433 4500 | ||
---|---|---|---|
005 | 20250518003252.0 | ||
264 | 0 | _c20191028 | |
008 | 201910s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/s41598-018-33727-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiranda, Pedro Henrique de A | |
245 | 0 | 0 |
_aOral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats. _h[electronic resource] |
260 |
_bScientific reports _c10 2018 |
||
300 |
_a15310 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHomeostasis _xdrug effects |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 |
_aQuercetin _xadministration & dosage |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVildagliptin _xadministration & dosage |
700 | 1 | _aLacerda, Kissyla Christine Duarte | |
700 | 1 | _aAraújo, Carolina Morais | |
700 | 1 | _aBarichello, José Mario | |
700 | 1 | _aLima, Wanderson Geraldo | |
700 | 1 | _aCosta, Daniela Caldeira | |
773 | 0 |
_tScientific reports _gvol. 8 _gno. 1 _gp. 15310 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-018-33727-x _zAvailable from publisher's website |
999 |
_c28951355 _d28951355 |